After the company's recent fall from grace, Amicus (FOLD 0.87%) shares are showing new life, up double digits in late-day trading. Today's pop follows a press release announcing solid phase 2 results for one of Amicus' pipeline drugs. On the other side of the coin, today's biggest loser was a company called Accuray (ARAY -1.53%), a medical devices stock down some 20% today after pre-announcing quarterly results last night after the market closed.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.